News Conference News EuroPCR 2024 POLMIDES: Hybrid Revascularization Bests CABG For 10-Year Survival Yael L. Maxwell May 22, 2024
News Conference News EuroPCR 2024 PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3 Yael L. Maxwell May 17, 2024
News Conference News EuroPCR 2024 TAVI, Surgery Look Similar Long-term Across Risk Spectrum: Meta-analysis Michael O'Riordan May 16, 2024
News Conference News EuroPCR 2024 Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids Michael O'Riordan May 15, 2024
News Conference News EuroPCR 2024 NOW PUBLISHED - Latest TAVI vs Surgery Trial Raises Eyebrows in Aortic Stenosis Plus CAD Michael O'Riordan May 14, 2024
News Conference News EuroPCR 2022 Self-Expanding TAVI Valves Offer Best Results in Small Failed Aortic Bioprostheses: LYTEN Caitlin E. Cox May 27, 2022
News Conference News EuroPCR 2022 Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot Michael O'Riordan May 23, 2022
News Conference News EuroPCR 2020 No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms Michael O'Riordan June 26, 2020
News Conference News EuroPCR 2019 Mortality Appears to Rise When SYNTAX II Score’s Advice for CABG Is Ignored: EXCEL Analysis L.A. McKeown June 07, 2019